Northern Pharmacy At Overlea is an authorized DME supplier for medicare equipments and products.
Northern Pharmacy At Overlea is a Community/Retail Pharmacy in Baltimore, Maryland. This pharmacy is owned and operated by Northern Phcy At Overlea Llc. It is located at 7618 Belair Rd, Baltimore and it's customer support contact number is 410-661-1655. The authorized person of Northern Pharmacy At Overlea is Pepper Mintz who is President And Coo of the pharmacy and his contact number is 410-254-2055. Active license number of Northern Pharmacy At Overlea is P04147 for Community/Retail Pharmacy in Maryland. Northern Pharmacy At Overlea accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Northern Pharmacy At Overlea is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Northern Pharmacy At Overlea type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Northern Pharmacy At Overlea
Type:
Community/Retail Pharmacy
Location:
7618 Belair Rd, Baltimore, Maryland, 21236-4088
Phone:
410-661-1655
Fax:
410-661-1822
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Pepper Mintz
Position:
President And Coo
Contact Number:
410-254-2055
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1093736043
NPI Enumeration Date:
22 Jul, 2006
NPI Last Update On:
26 Aug, 2016
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Northern Pharmacy At Overlea are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
P04147
Maryland
Primary
Durable Medical Equipment & Medical Supplies
Secondary
Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
2037909
Other
Pk
002883500
Medicaid
Maryland
Medicare Enrollment:
Northern Pharmacy At Overlea is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
9537370747
O20100930087127
Northern Phcy At Overlea Llc
DME SUPPLIER - PHARMACY
Products Available:
Northern Pharmacy At Overlea has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Heat & Cold Applications
Orthoses: Off-the-shelf
Seat Lift Mechanisms
Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7618 Belair Rd, Baltimore, Maryland
Zip:
21236-4088
Phone Number:
410-661-1655
Fax Number:
410-661-1822
Patients can reach Northern Pharmacy At Overlea at 7618 Belair Rd, Baltimore, Maryland or can call on customer care at 410-661-1655.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.